StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report published on Friday. The firm issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
SRNE opened at $0.01 on Friday. Sorrento Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25. The business has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.01.
Sorrento Therapeutics Company Profile
Want More Great Investing Ideas?
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- EV Stocks and How to Profit from Them
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- ETF Screener: Uses and Step-by-Step Guide
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Find and Profitably Trade Stocks at 52-Week Lows
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.